INFORMED MEDICAL COMMUNICATIONS HIGHLIGHTS OPPORTUNITY IN REVISED PHRMA CODE

Edison, NJ - August 11, 2008 - Informed Medical Communications (IMC), a leading provider of peer-to-peer medical forums for the bio-pharmaceutical industry, issued its position today on recent revisions to the PhRMA Code. “IMC remains fully committed to compliance with the PhRMA Code,” noted Dr. Jaime Nguyen, Medical Director/Compliance Officer for IMC. “Though the guidelines have changed, we have continually monitored the compliance trends so that our services can remain a valuable resource for our clients in reaching their customers.”

With the ongoing restrictions on sales representative involvement, IMC (including The Peer Group and RxDialogue) has always proactively evolved its services to maintain the highest level of compliance rigor, enabling their clients a safe option for effectively meeting the needs of their brands. “IMC’s medical communications will continue to be one of the few available tactics offering high-impact results for brand teams because its informational presentations and interactive discussions improve patient care and increase exposure to disease states and therapeutic choices,” noted Kathleen Bresette, President of The Peer Group. Additionally, IMC’s unique use of compliance-trained clinical Moderators ensures a viable, valuable method for supporting biopharmaceutical brands.

Steve Budd, CEO of IMC commented “Because of this changing regulatory environment, IMC continually scrutinizes the compliance of its services, imbuing in our clients a confidence that IMC medical communications services like our Moderator Advantage Programs (MAPs) and teleconferences will remain an ideal tactic for discussing promotional on-label brand messages with healthcare professionals.”